Characterize longitudinal events of oral high-risk human papillomavirus among an at-risk population (CLEAR)
Project Number1R01DE033862-01
Contact PI/Project LeaderNOWAK, REBECCA G.
Awardee OrganizationUNIVERSITY OF MARYLAND BALTIMORE
Description
Abstract Text
Project Summary/Abstract
Males living with HIV are estimated to be at a 2- to 5-fold higher risk of developing human papillomavirus-
related oropharyngeal cancer (HPV-OPC) compared to the general population, with up to 90% of cases
attributed to oral high-risk (oHR)-HPV16. Because precancerous lesions are a challenge to diagnose and
clinicians have no reliable means of identifying vulnerable patients, effective interventions will require a
thorough understanding of the natural history of oHR-HPV. The presence of persistent non-oral HR-HPV
precedes precancerous lesion development in other HPV-related cancers; the same may be true for oHR-HPV.
HIV and anti-retroviral therapy (ART) may alter the oral microbiome and give rise to oral lesions and
periodontal disease, creating an immune microenvironment conducive to persistent oHR-HPV that ultimately
increases the risk for HPV-OPC. Predictors of oHR-HPV infection and persistence could serve as detection
markers for HPV-OPC to prompt preventive treatment early in disease progression when treatment outcomes
are most favorable. We propose to conduct a prospective study to characterize longitudinal events of oHR-
HPV among an at-risk population (CLEAR). We will leverage our longstanding multidisciplinary and
international collaboration and the established cohort receiving care at the sexual and gender minority-friendly
TRUST clinic in Nigeria. A total of 1,200 HPV-unvaccinated Nigerian non-heterosexual males who perform oral
sex and are living with or without HIV will be screened for oHR-HPV. A subset of 500 males, including those
with a prevalent oHR-HPV will be followed every 3 months for up to 2 years. We will collect oral gargle and
blood samples to detect incident and persistent oHR-HPV infection; measure CD4, HIV viral load, and the oral
microbiome; characterize oral sex practices; and perform dental examinations to document periodontal
disease, oral lesions, and dental caries. We will determine the association between HIV clinical markers and
oral-anogenital contact and the prevalence of oHR-HPV (AIM 1). We will compare the time course of oHR-HPV
as a function of HIV status (AIM 2). We will evaluate the relationship between dental phenotypes, the oral
microbiome, HIV clinical measures, and oHR-HPV infection (AIM 3). Understanding the oHR-HPV burden, time
course of infection, and oral cavity indicators of the immune microenvironment in the context of HIV will
generate robust data needed to help inform predictive models and develop rational risk-stratified screening
algorithms to help mitigate risk of HPV-OPC in males living with HIV.
Public Health Relevance Statement
Project Narrative
This large, population-based study will reveal the relationship between HIV and the natural history of oral
human papillomavirus (HPV) infection in an at-risk cohort of males living with HIV. This information will be
critical for developing screening algorithms to identify males at high risk of developing HPV-related
oropharyngeal cancer (HPV-OPC), who would benefit from preventive treatment or early-stage treatment
when outcomes are most favorable. Ultimately, the knowledge gained from this study will translate into
strategies to mitigate the risk of HPV-OPC among males living with HIV.
National Institute of Dental and Craniofacial Research
CFDA Code
121
DUNS Number
188435911
UEI
Z9CRZKD42ZT1
Project Start Date
01-September-2024
Project End Date
31-May-2029
Budget Start Date
01-September-2024
Budget End Date
31-May-2025
Project Funding Information for 2024
Total Funding
$598,940
Direct Costs
$437,714
Indirect Costs
$161,226
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Dental and Craniofacial Research
$598,940
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R01DE033862-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01DE033862-01
Patents
No Patents information available for 1R01DE033862-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01DE033862-01
Clinical Studies
No Clinical Studies information available for 1R01DE033862-01
News and More
Related News Releases
No news release information available for 1R01DE033862-01
History
No Historical information available for 1R01DE033862-01
Similar Projects
No Similar Projects information available for 1R01DE033862-01